Medicare Enrolled
Dr. Calvin Abro, MD
Hematology & Oncology · Battle Creek, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Abro from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abro?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Abro
Dr. Calvin Abro is a hematology & oncology specialist in Battle Creek, MI, with 8 years of NPI registration. Based on federal Medicare data, Dr. Abro performed 314 Medicare services across 260 unique beneficiaries.
Between the years covered by Open Payments, Dr. Abro received a total of $7,950 from 63 pharmaceutical and/or device companies across 293 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Abro is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 8 years in practice
▲ 314 Medicare services
$7,950 industry payments
Medicare Practice Summary
Medicare Utilization ↗314
Medicare services
Bottom 28% in MI for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
260
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~39 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
43 | $8 | $40 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
39 | $8 | $15 |
| New patient office visit, complex (60-74 min) | 33 | $176 | $364 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
32 | $97 | $185 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
30 | $10 | $40 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
30 | $142 | $330 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
28 | $132 | $300 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $98 | $175 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
23 | $145 | $251 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
16 | $65 | $130 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
12 | $92 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,950
Total received (2018-2024)
Avg $1,325/year across 6 years
Top 23% in MI for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
293
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,307 (91.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$643 (8.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,381
2023
$2,034
2022
$14
2021
$73
2019
$239
2018
$209
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$646
PFIZER INC.
$368
AstraZeneca Pharmaceuticals LP
$328
Incyte Corporation
$245
Takeda Pharmaceuticals U.S.A., Inc.
$238
E.R. Squibb & Sons, L.L.C.
$234
Daiichi Sankyo Inc.
$231
Astellas Pharma US Inc
$221
ABBVIE INC.
$202
SOBI, INC
$191
Medtronic, Inc.
$175
Exelixis Inc.
$164
Merck Sharp & Dohme LLC
$160
Regeneron Healthcare Solutions, Inc.
$151
Novartis Pharmaceuticals Corporation
$130
Celgene Corporation
$111
GENZYME CORPORATION
$105
Genentech USA, Inc.
$104
Tempus AI, Inc
$100
ARRAY BIOPHARMA INC
$98
Adaptive Biotechnologies Corporation
$92
SERVIER PHARMACEUTICALS LLC
$91
Stemline Therapeutics Inc.
$83
Eisai Inc.
$79
EMD Serono, Inc.
$76
Bayer Healthcare Pharmaceuticals Inc.
$68
GlaxoSmithKline, LLC.
$61
PharmaEssentia USA Corporation
$60
Kyowa Kirin, Inc.
$51
Ipsen Biopharmaceuticals, Inc
$51
TerSera Therapeutics LLC
$40
Agios Pharmaceuticals, Inc.
$40
TAIHO ONCOLOGY, INC.
$39
JAZZ PHARMACEUTICALS INC.
$34
Myriad Genetic Laboratories, Inc.
$30
Acrotech Biopharma Inc.
$29
Napo Pharmaceuticals Inc
$28
Lilly USA, LLC
$28
Deciphera Pharmaceuticals Inc.
$26
Biocon Biologics Inc
$24
Coherus Biosciences Inc.
$24
Amneal Pharmaceuticals LLC
$24
Rigel Pharmaceuticals, Inc.
$23
Cumberland Pharmaceuticals, Inc.
$20
Sumitomo Pharma America, Inc.
$20
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
Pharmacosmos Therapeutics Inc.
$18
Top 3 companies account for 24.9% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$904
PFIZER INC.
$487
E.R. Squibb & Sons, L.L.C.
$358
AstraZeneca Pharmaceuticals LP
$348
GlaxoSmithKline, LLC.
$347
Novartis Pharmaceuticals Corporation
$338
Seagen Inc.
$332
Takeda Pharmaceuticals U.S.A., Inc.
$290
Incyte Corporation
$282
Regeneron Healthcare Solutions, Inc.
$276
Merck Sharp & Dohme LLC
$254
Astellas Pharma US Inc
$244
Daiichi Sankyo Inc.
$231
Celgene Corporation
$229
SOBI, INC
$215
ABBVIE INC.
$202
Medtronic, Inc.
$175
Exelixis Inc.
$164
GENZYME CORPORATION
$140
Stemline Therapeutics Inc.
$128
ARRAY BIOPHARMA INC
$117
Merck Sharp & Dohme Corporation
$106
Genentech USA, Inc.
$104
Tempus AI, Inc
$100
EMD Serono, Inc.
$94
Adaptive Biotechnologies Corporation
$92
SERVIER PHARMACEUTICALS LLC
$91
Janssen Pharmaceuticals, Inc
$82
Eisai Inc.
$79
Kyowa Kirin, Inc.
$75
Ipsen Biopharmaceuticals, Inc
$74
Bayer Healthcare Pharmaceuticals Inc.
$68
PharmaEssentia USA Corporation
$60
Pharmacyclics LLC, An AbbVie Company
$56
JAZZ PHARMACEUTICALS INC.
$54
Deciphera Pharmaceuticals Inc.
$51
Karyopharm Therapeutics Inc.
$42
TerSera Therapeutics LLC
$40
Agios Pharmaceuticals, Inc.
$40
TAIHO ONCOLOGY, INC.
$39
Coherus Biosciences Inc.
$38
Shield Therapeutics Inc
$34
Myriad Genetic Laboratories, Inc.
$30
Acrotech Biopharma Inc.
$29
Amgen Inc.
$29
Napo Pharmaceuticals Inc
$28
Lilly USA, LLC
$28
Biocon Biologics Inc
$24
G1 Therapeutics, Inc.
$24
Foundation Medicine, Inc.
$24
Amneal Pharmaceuticals LLC
$24
Kite Pharma, Inc.
$23
Rigel Pharmaceuticals, Inc.
$23
ACCORD HEALTHCARE, INC.
$22
Cumberland Pharmaceuticals, Inc.
$20
Sumitomo Pharma America, Inc.
$20
BeiGene USA, Inc.
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
Pharmacosmos Therapeutics Inc.
$18
Mirati Therapeutics, Inc.
$18
ImmunoGen, Inc.
$17
Alexion Pharmaceuticals, Inc.
$16
Novo Nordisk Inc
$14
Top 3 companies account for 22.0% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADCETRIS · ADVATE · ALUNBRIG · AUGTYRO · AVASTIN · BESREMI · BEVESPI AEROSPHERE · BOSULIF · BRUKINSA · Blincyto · CABOMETYX · CAMCEVI · CARVYKTI · COSELA · DARZALEX · DIFICID · DOPTELET · Doptelet · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Elahere · Enhertu · FRUZAQLA · Fabhalta · Fulphila · GELCLAIR CONCENTRATED ORAL GEL · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · INJECTAFER · INLYTA · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUPRON DEPOT · LYNPARZA · Lenvima · MAYZENT · NINLARO · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OSTEOCOOL RF ABLATION SYSTEM · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PLUVICTO · PRECISETUMOR · PYRUKYND · Phesgo · Polivy · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RYBREVANT · RYZNEUTA · Rezlidhia · SANCUSO · SARCLISA · SHINGRIX · Stivarga · TABRECTA · TAGRISSO · TECVAYLI · TIVDAK · TUKYSA · Tazverik · Tecentriq · Tibsovo · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VONJO · Venclexta · XALKORI · XARELTO · XPOVIO · XT CDX · XTANDI · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZERBAXA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
11
Per 100K population
8.2
County median income
$60,385
Nearest hospital
BRONSON BATTLE CREEK HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Abro is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Abro experienced with complete blood count (cbc) with differential?
Based on Medicare claims data, Dr. Abro performed 43 complete blood count (cbc) with differential services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Abro receive payments from pharmaceutical companies?
Yes. Dr. Abro received a total of $7,950 from 63 companies across 293 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abro's costs compare to other hematology & oncology specialists in Battle Creek?
Dr. Abro's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abro) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Battle Creek
Browse hematology & oncology specialists in Battle Creek ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in MI
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in MI
Which MI hematology & oncology specialists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology